Unique ID issued by UMIN | UMIN000045214 |
---|---|
Receipt number | R000051648 |
Scientific Title | We propose a new controlled ovarian hyperstimulation (COH) protocol for polycystic ovary syndrome (PCOS). |
Date of disclosure of the study information | 2021/08/21 |
Last modified on | 2021/08/21 09:52:11 |
We propose a new controlled ovarian hyperstimulation (COH) protocol for polycystic ovary syndrome (PCOS).
We propose a new controlled ovarian hyperstimulation (COH) protocol for polycystic ovary syndrome (PCOS).
We propose a new controlled ovarian hyperstimulation (COH) protocol for polycystic ovary syndrome (PCOS).
We propose a new controlled ovarian hyperstimulation (COH) protocol for polycystic ovary syndrome (PCOS).
Japan |
Polycystic ovary syndrome(PCOS)
Obstetrics and Gynecology |
Others
NO
We have developed new controlled ovarian stimulation (COS) method for polycystic ovary syndrome (PCOS) avoids ovarian hyperstimulation syndrome (OHSS) and produces higher-quality oocytes and verify on its efficacy and safety.
Safety,Efficacy
Confirmatory
Pragmatic
Phase III
To establish a new controlled ovarian stimulation (COS) protocol for polycystic ovary syndrome (PCOS) that does not cause ovarian hyper stimulation syndrome (OHSS) while maintaining egg quality.
1)No adverse and after effect for ovarian function following using this COS
2)Comparison of proportions of fertilization, pregnancy and abortion with those of base line levels.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine | Maneuver |
From the third (or fifth) day of the period, 5mg (or 2.5mg) of Letrozole and 150iu of HMG were administered every day until the day of trigger administration. When the leading follicle reached 18mm in diameter, the injection of 0.25mg of GnRH antagonist started and continued until the day of the trigger shot. After confirmation that the largest follicle was 22-24 mm in diameter and E2 level was about 500-700pg/ml, 5000iu of HCG was administered as trigger and oocyte collection was performed 37 hours later under general anesthesia with Propofol. All embryos were cryopreserved after IVF or ICSI. 2.5mg of Letrozole, 0.5mg of Cabergoline and 0.25mg of GnRH antagonist were administered just after the oocyte retrieval for five days consecutively.
20 | years-old | <= |
40 | years-old | > |
Female
1)Patient of Polycystic ovary syndrome(PCOS)
2)Married women
1)Patients with Severe Type2 diabetes.
2)Patients and Husband who can not obtain written informed consent.
3)Patients judged to be inappropriate for the study by the physicians.
50
1st name | Atsushi |
Middle name | |
Last name | Tanaka |
Saint Mother Clinic
Medical office
807-0825
4-9-12 Orio Yahatanishiku, Kitakyusyu Fukuoka, Japan
093-601-2000
incho@stmother.com
1st name | Atsushi |
Middle name | |
Last name | Tanaka |
Saint Mother Clinic
Medical office
Medical office
4-9-12 Orio Yahatanishiku, Kitakyusyu Fukuoka, Japan
093-601-2000
incho@stmother.com
Saint Mother Clinic
Saint Mother Clinic
Self funding
Saint Mother Clinic Institutional Review Board
4-9-12 Orio Yahatanishiku, Kitakyusyu Fukuoka, Japan
093-691-6004
soumu@stmother.com
NO
2021 | Year | 08 | Month | 21 | Day |
Unpublished
Open public recruiting
2021 | Year | 08 | Month | 06 | Day |
2021 | Year | 08 | Month | 06 | Day |
2021 | Year | 08 | Month | 06 | Day |
2023 | Year | 03 | Month | 31 | Day |
2021 | Year | 08 | Month | 21 | Day |
2021 | Year | 08 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051648